Approaches for Overcoming Obstacles to Successful Implementation in the Clinic Biomarkers have become some of the most desired clinical and research tools in the life sciences. They have the potential ...

NOTCH3-ECD is a specific IPAH biomarker, Cloud-Clone’s SEL147Hu ELISA Kit powers this breakthrough HUSTON, TX, UNITED STATES, March 17, 2026 /EINPresswire.com/ — A groundbreaking study published in ...

FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...

Collaborative research is underway to translate scientific discovery into actionable evidence ...

GENT, Belgium & FREMONT, Calif.--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

The integration of proteomics in biomarker discovery represents a major advancement in molecular diagnostics and precision medicine. Researchers seek highly specific indicators of complex disease ...

One of the earliest examples of a vaccine biomarker assay still in use is the polio antibody neutralization assay, which evaluates the immunogenicity of different polio vaccines. This assay is used to ...

New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted ...

The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...